111

111 EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 111 (YI) as of Oct 31, 2026 is -10.03 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 2.11 M CNY — a change of -574.37% (lower).

EBITDA

-10.03 MCNY

YoY

-574.37%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 111 is 2025 -10.03 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 111 was 2024 2.11 M CNY. It decreases by -574.37% lower compared to the previous year.

The 111 EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
-400.38 M CNY
Jan 1, 2019
-493.51 M CNY
Jan 1, 2020
-473.31 M CNY
Jan 1, 2021
-642.14 M CNY
Jan 1, 2022
-362.63 M CNY
Jan 1, 2023
-333.04 M CNY
Jan 1, 2024
2.11 M CNY
Jan 1, 2025
-10.03 M CNY
The 111 EBITDA history
YEAREBITDAYoY
-10.03 MCNY-574.37%
2.11 MCNY-100.63%
-333.04 MCNY-8.16%
-362.63 MCNY-43.53%
-642.14 MCNY+35.67%
-473.31 MCNY-4.09%
-493.51 MCNY+23.26%
-400.38 MCNY+57.61%
-254.02 MCNY-30.27%
-364.28 MCNY—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

111 Stock analysis

What does 111 do? 111 Inc, trading under the ticker YI and ISIN US68247Q2012, is a company based in Shanghai, China, operating within the Consumer Staples sector and Retail industry. The company went public on September 12, 2018. According to the provided information, 111 Inc is engaged in the provision of pharmaceutical products and medical services through online retail pharmacy and an indirect offline pharmacy network. The company's website is http://gangling.111.com.cn/. The employee count provided in the user message is 144, though the source description mentions 1,932 full-time employees, which is inconsistent. The company focuses on online medical services, drug purchasing, and health management services utilizing internet and information technology. It primarily serves the domestic market in China. The company's headquarters are located in Shanghai, Shanghai, and it operates with a focus on retail and consumer staples within the pharmaceutical and healthcare services domain. 111 is one of the most popular companies on Eulerpool.

Frequently Asked Questions about 111 stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 111 is -10.03 M CNY in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of 111 changed from 2.11 M CNY to -10.03 M CNY, representing a -574.37% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) 111 since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s 111 historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Income Statement — 111

All Key Metrics — 111